Presentation Operator Message
Operator (Operator)
Good day, and thank you for standing by. Welcome to the results of LEGEND Phase II combination trial with lanifibranor and Empagliflozin in patients
I
|
Temps réel
Euronext Paris
14:23:15 05/11/2026
|
Varia. 5j. | Varia. 1 janv. | ||
| 3,555 EUR | +0,28 % |
|
+6,73 % | -9,51 % |
| 03/11 | JPMorgan Chase sous les 5% des droits de vote d'Inventiva | |
| 02/10 | Inventiva S.A. : Opinion positive de Truist Securities | ZM |
Publié le 19/03/2024 à 13:00
Presentation Operator Message
Operator (Operator)
Good day, and thank you for standing by. Welcome to the results of LEGEND Phase II combination trial with lanifibranor and Empagliflozin in patients
I
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national